Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | SSTR1 | P30872 | 1/20 | 0.32 |
| ▸ | SSTR4 | P31391 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tert-Butyl Formate SCHEMBL28036613 | 0.90 | TDP1 (0.43) | TDP1 | |
| Tert-Butyl Formate SCHEMBL28165086 | 0.90 | TDP1 (0.43) | TDP1 | |
| Tert-Butyl Formate SCHEMBL27987725 | 0.86 | TDP1 (0.46) | TDP1EPHX1POLBSSTR1SSTR4 | |
| Tert-Butyl Formate SCHEMBL27852871 | 0.84 | TDP1 (0.45) | TDP1EPHX1POLBSSTR1SSTR4 | |
| Tert-Butyl Formate SCHEMBL27852257 | 0.83 | TDP1 (0.43) | TDP1EPHX1POLBSSTR1SSTR4 | |
| Tert-Butyl Formate SCHEMBL27990522 | 0.81 | TDP1 (0.50) | TDP1 | |
| Tert-Butyl Formate SCHEMBL27764923 | 0.81 | KCNH2 (0.49) | TDP1EPHX1SSTR1SSTR4 | |
| Tert-Butyl Formate SCHEMBL28291359 | 0.81 | TDP1 (0.54) | TDP1 | |
| Tert-Butyl Formate SCHEMBL27731450 | 0.79 | TDP1 (0.52) | TDP1 | |
| Tert-Butyl Formate SCHEMBL28092916 | 0.78 | TDP1 (0.68) | TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109970743-A | 5-chloro-2-difluoromethoxyphenyl pyrazolopyrimidine compounds as JAK inhibitors | 豪夫迈·罗氏有限公司 | 2019-07-05 | — | — | CN | disclosed |
| CN-109071490-A | Acyclic derivatives | 默克专利股份公司 | 2018-12-21 | — | — | CN | disclosed |
| CN-106459039-A | 5-chloro-2-difluoromethoxyphenyl pyrazolopyrimidine compounds as JAK inhibitors | 豪夫迈·罗氏有限公司 | 2017-02-22 | — | — | CN | disclosed |
| CN-103402977-B | Ingenol-3-acylate III and ingenol-3-carbamate | LEO PHARMA A/S (IE) | 2016-01-20 | — | — | CN | disclosed |
| CN-103724328-B | Cyclic pyrimidin-4-the methane amide of inflammation, asthma and COPD is used for the treatment of as CCR2 receptor antagonist | BOEHRINGER INGELHEIM INT (DE) | 2015-10-14 | — | — | CN | disclosed |
| CN-104650092-A | Substituted ceteroary compound as well as composition and application thereof | GUANGDONG HEC PHARMACEUTICAL | 2015-05-27 | — | — | CN | disclosed |
| CN-104529827-A | Ingenol-3-acylates III and ingenol-3-carbamates | LEO PHARMA AS | 2015-04-22 | — | — | CN | disclosed |
| CN-102361863-B | Novel bicyclic antibiotics | BASILEA PHARMACEUTICA AG | 2014-12-03 | — | — | CN | disclosed |
| CN-102256963-B | Cyclic pyrimidine-4-carboxamides as CCR2 receptor antagonists for the treatment of inflammation, asthma and COPD | BOEHRINGER INGELHEIM INT | 2014-06-11 | — | — | CN | disclosed |
| CN-103724328-A | Cyclic pyrimidin-4-carboxamides as ccr2 receptor antagonists for treatment of inflammation, asthma and copd | BOEHRINGER INGELHEIM INT | 2014-04-16 | — | — | CN | disclosed |
| CN-102361863-A | Novel bicyclic antibiotics | BASILEA PHARMACEUTICA AG | 2012-02-22 | — | — | CN | disclosed |
| CN-101087794-B | Pharmaceutical compounds | HOFFMANN LA ROCHE | 2011-05-18 | — | — | CN | disclosed |
| CN-101835779-A | Purine derivative as the PI3 kinase inhibitor | HOFFMANN LA ROCHE | 2010-09-15 | — | — | CN | disclosed |
| CN-100480249-C | Pyrrolopyridine-2-carboxylic acid amides as glycogen phosphorylase inhibitors | PROSIDION LTD (GB) | 2009-04-22 | — | — | CN | disclosed |
| CN-101087794-A | Pharmaceutical compounds | PIRAMED LTD (GB) | 2007-12-12 | — | — | CN | disclosed |
| CN-1870991-A | Substituted indoles as inhibitors of poly (ADP-ribose) polymerase (PARP) | AVENTIS PHARMA INC (US) | 2006-11-29 | — | — | CN | disclosed |
| CN-1826340-A | Pyrrolopyridine-2-carboxylic acid amides as glycogen phosphorylase inhibitors | PROSIDION LTD (GB) | 2006-08-30 | — | — | CN | disclosed |
| CN-1098838-C | Substituted N- (indole-2-carbonyl) -beta-alaninamides and derivatives as antidiabetics | PFIZER (US) | 2003-01-15 | — | — | CN | disclosed |
| CN-1374082-A | Use of glycogen sulphofoenzyme inhibitor | PFIZER (US) | 2002-10-16 | — | — | CN | disclosed |
| CN-1140709-A | Substituted N- (indole-2-carbonyl) -beta-alaninamides and derivatives as antidiabetics | PFIZER (US) | 1997-01-22 | — | — | CN | disclosed |